Security Snapshot

FOUNDATION MEDICINE INC - COM (FMI) Institutional Ownership

CUSIP: 350465100

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2018

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • FMI - FOUNDATION MEDICINE INC - COM is tracked under CUSIP 350465100.
  • Latest finished 13F holder period is not available.
  • Schedule 13D/13G significant owner rows are not currently available.

Change

  • Holder count moved from 154 to 0 between Q2 2018 and Q3 2018.
  • SEC-reported value moved from $1,853,983,797 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

350465100

Latest holder period

n/a

13F holders

13D/G owners

0

CIK / CUSIP context first

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
19
Latest
n/a
Rows shown
1-19 of 19
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2018 Q3 0 $0 -$1,853,074,577 0
2018 Q2 13,562,413 $1,853,983,797 +$282,858,148 $136.70 154
2018 Q1 12,524,869 $986,164,804 +$82,733,271 $78.75 144
2017 Q4 11,478,196 $782,795,574 +$37,711,667 $68.20 124
2017 Q3 11,847,293 $476,204,732 +$13,851,919 $40.20 95
2017 Q2 11,470,189 $455,967,811 +$11,812,038 $39.75 102
2017 Q1 11,191,395 $360,925,031 +$46,570,342 $32.25 91
2016 Q4 11,289,562 $199,874,276 -$8,116,226 $17.70 94
2016 Q3 11,217,483 $261,901,406 +$10,596,391 $23.35 103
2016 Q2 10,817,686 $201,853,680 -$5,741,154 $18.66 91
2016 Q1 11,103,030 $201,773,284 -$5,714,344 $18.18 93
2015 Q4 11,374,902 $239,528,313 -$19,397,945 $21.06 97
2015 Q3 12,165,033 $224,434,151 +$135,502 $18.45 84
2015 Q2 11,734,938 $397,085,381 -$424,764,862 $33.84 96
2015 Q1 21,449,695 $1,031,943,094 +$35,872,997 $48.11 97
2014 Q4 21,501,328 $477,758,620 +$32,662,494 $22.22 90
2014 Q3 19,862,116 $376,578,904 +$13,419,652 $18.96 81
2014 Q2 18,659,586 $503,067,003 +$1,682,796 $26.96 96
2014 Q1 18,487,228 $598,370,301 +$10,283,954 $32.37 88
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .